• Our Partners
  • CarePolicy
  • HomeCareConsulting
  • Digit9X
  • Home
  • Assisted Living
  • Elderly
  • Home Care Agency
  • Home Care Worker
  • Home Nursing
Menu
  • Home
  • Assisted Living
  • Elderly
  • Home Care Agency
  • Home Care Worker
  • Home Nursing
Home » Activated Carbon For Pharma & Healthcare Market Report, 2030
Elderly

Activated Carbon For Pharma & Healthcare Market Report, 2030

adminBy adminMay 5, 2025No Comments9 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr Email Reddit
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link


Market Size & Trends

The global activated carbon for pharma & healthcare market size was estimated at USD 450.1 million in 2024 and is expected to expand at a CAGR of 6.3% from 2025 to 2030. Its exceptional purification and adsorption properties propel the rising demand for activated carbon in the pharmaceutical and healthcare sectors. It plays a crucial role in applications such as air and water purification in hospitals and pharmaceutical manufacturing, as it eliminates impurities and decolorants from medications.

Activated Carbon For Pharma & Healthcare Market Size, By Form, 2020 - 2030 (USD Million)

The growing demand for activated carbon in the healthcare sector is closely linked to the high incidence of hospital-acquired infections (HAIs) in the U.S. Each year, around 1.7 million inpatients-roughly one in every 20-contract an HAI, with 5%-10% of hospitalized patients affected and nearly 100,000 resulting deaths. These alarming figures surpass the incidence and mortality rates of many other reportable diseases, highlighting the urgent need for advanced air and water purification solutions  Activated carbon, known for its effective filtration and adsorption capabilities, is increasingly being adopted to help maintain sterile environments and reduce the risk of infection in medical facilities.

Furthermore, their demand is driven by their essential role in decolorization and purification. Its highly porous structure, enhanced through thermal activation, allows for efficient impurities, pigments, and dyes adsorption. This improves product quality, safety, and appearance . Activated carbon is widely used during production to trap unwanted substances, ensuring cleaner, more effective drugs. The industry’s increasing R&D investments further fuel the need for high-performance purification solutions such as activated carbon. These factors fuel the demand for activated carbon for the pharma & healthcare industry.

Form Insights

The powdered form dominated the activated carbon for the pharma & healthcare market with the largest revenue share of 56.3% in 2024. Powdered Activated Carbon (PAC) has proven effective in reducing pharmaceutical compounds in wastewater, with a 63-84% reduction in discharged carbamazepine and diclofenac at dosing levels of 10-25 mg/L. PAC is an essential tool for controlling pharmaceutical contaminants in municipal wastewater treatment. It also enhances sludge quality, increasing the dry weight by +1% while limiting the sludge production increase to 7-9%, contributing to more efficient waste management

The granular activated carbon segment is expected to grow at the fastest CAGR of 6.9% over the forecast period. The granular form is increasingly preferred by pharma and healthcare companies owing to its key properties, such as superior absorption, ease of handling and storage, and regeneration capacity. The ability of granular activated carbon to withstand the repeated cycles of filtration primarily drives the growing adoption. Increasing collaborations and supply contracts among market participants also contribute to the growth experience of this segment. In 2024, Arq, Inc., one of the key manufacturers of Granular Activated Carbon (GAC), announced that it secured multiple supply contracts for its GAC product, mainly designed for processes associated with raw material purification.

Application Insights

The API production dominated the activated carbon for pharma & healthcare industry with the largest revenue share in 2024. During API production, which is the key component of medicines, responsible for their therapeutic effects, activated carbon helps remove impurities, decolorization, pH adjustment, stability, prevent contamination, and enhance product quality. The pharmaceutical industry is one of the most rapidly evolving sectors worldwide, with active pharmaceutical ingredients playing a central role.

Activated Carbon For Pharma & Healthcare Market Share, By Application, 2024 (%)

The finished drug production segment is expected to grow significantly over the forecast period. Activated carbon plays a key role in pharmaceutical wastewater treatment, removing residual drugs and contaminants to ensure environmental compliance after drug production.

Regional Insights

The activated carbon for pharma & healthcare market in Asia Pacific dominated the global market with the largest revenue share of 48.6% in 2024. The demand is rising due to rapid industrialization and urbanization. Increased pharmaceutical production in Asian countries further drives the need for efficient purification. Leading companies such as Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., and Cipla contribute significantly to this demand, using activated carbon in various drug manufacturing and filtration processes.

Activated Carbon For Pharma & Healthcare Market Trends, by Region, 2025 - 2030

China Activated Carbon For Pharma & Healthcare Market Trends

The activated carbon for pharma & healthcare market in China dominated the Asia Pacific market with the largest revenue share in 2024. China’s expanding pharmaceutical and healthcare sectors fuel demand for activated carbon, essential for purifying APIs and intermediates in drug production. Since 2021, the industry has grown at an average annual rate of 9.3%, driven by the 14th Five-Year Plan, according to the Ministry of Industry and Information Technology. Strict environmental regulations on pharmaceutical emissions and waste management have increased the use of activated carbon for air and water purification. In addition, activated carbon tablets and capsules are widely used in hospitals and pharmacies to treat poisoning, indigestion, and flatulence.

North America Activated Carbon For Pharma & Healthcare Market Trends

The activated carbon for pharma & healthcare market in North America held a substantial market share in 2024. The growing pharmaceutical manufacturing industries and advancements in cleaner healthcare sectors are driving the market demand. Furthermore, it is used to treat over-the-counter stomach issues, which are continuously increasing according to the American Gastroenterological Association (AGA). In 2022, it was reported that 60-70 million Americans were suffering from gastrointestinal diseases . In addition, North America accounted for 49.1% of global pharmaceutical sales  in 2021, indicating the region’s dominant position in the global pharma market, accelerating the demand for activated carbon.

The U.S. activated carbon for pharma & healthcare market led the North American market, accounting for the largest revenue share in 2024. The growing demand is driven by several key factors, such as increasing regulatory pressures from agencies such as the FDA, along with stricter environmental guidelines, which are pushing companies to adopt higher standards of purity and filtration in drug manufacturing. Activated carbon meets these standards by removing impurities from active pharmaceutical ingredients and intermediates. Its medical applications, particularly in treating drug overdoses, have become increasingly vital, highlighted by the 105,007 overdose deaths reported in 2023 . Rising environmental and health awareness also encourages cleaner and more sustainable production practices in the healthcare sector.

Europe Activated Carbon For Pharma & Healthcare Market Trends

The activated carbon for pharma & healthcare market in Europe held a substantial market share in 2024. The increasing demand is largely driven by its expanding use across various industries, including pharmaceuticals. In 2022, the pharmaceutical sector invested over USD 53.5 million in R&D  in Europe. Furthermore, the growing digestive disorder in the region is a major driver for activated carbon, as it helps manage certain symptoms. According to a report from United European Gastroenterology (UEG), in 2023, over 332 million people are estimated to be living with a digestive disorder in the region. 

Key Activated Carbon For Pharma & Healthcare Company Insights

Some major companies in the activated carbon for pharma & healthcare industry are Osaka Gas Chemicals Co., Ltd., Calgon Carbon Corporation, JACOBI CARBONS GROUP, and Cabot Corporation. These companies focus on innovating purification technologies, ensuring compliance with stringent regulatory standards, and expanding product applications. They focus on high-quality, efficient solutions for pharmaceutical manufacturing, wastewater treatment, and medical uses such as poisoning treatments. Strong R&D investments and strategic partnerships with leading pharma companies also help sustain growth.


Osaka Gas Chemicals Co., Ltd. produces materials such as activated carbon, carbon fiber, fine chemicals, and wood preservatives. The company serves various industries, including pharmaceuticals, electronics, and environmental sectors, and it focuses on innovation and sustainability in its product offerings and operations.



Calgon Carbon Corporation manufactures coal, wood, and coconut-based activated carbon products in granular, powdered, pelletized, and cloth forms.


Key Activated Carbon For Pharma & Healthcare Companies:

The following are the leading companies in the activated carbon for pharma & healthcare market. These companies collectively hold the largest market share and dictate industry trends.


Jacobi Group
Chemviron (a Kuraray Company)
Haycarb PLC
Boyce Carbon
Southern Carbon Pvt. Ltd.
Suneeta Carbons
Calgon Carbon Corporation
Karbonous Inc.
Norit
Donau Carbon GmbH

Recent Developments


In February 2025, JACOBI CARBONS GROUP announced that a 15-20% price increase would be implemented from April 2025 on all coconut shell-based activated carbons. A recent surge in raw material costs necessitated the adjustment.



In December 2024, CPL/Puragen Activated Carbons, ADBA members, won the Energy Innovation award at the MRW National Recycling Awards 2024 for their breakthrough in reactivating high-sulfur spent carbon from the biogas sector-a previously untreatable waste.


Activated Carbon For Pharma & Healthcare Market Report Scope




Report Attribute



Details





Market size value in 2025



USD 479.7 million





Revenue forecast in 2030



USD 652.1 million





Growth rate



CAGR of 6.3% from 2025 to 2030





Base year for estimation



2024





Historical data



2018 – 2023





Forecast period



2025 – 2030





Quantitative units



Volume in kilotons, revenue in USD million, and CAGR from 2025 to 2030





Report coverage



Volume & revenue forecast, company ranking, competitive landscape, growth factors, and trends





Segments covered



Form, application, region





Regional scope



North America; Europe; Asia Pacific; Latin America; Middle East & Africa





Country scope



U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; South Africa; Saudi Arabia





Key companies profiled



Jacobi Group; Chemviron (a Kuraray Company); Haycarb PLC; Boyce Carbon; Southern Carbon Pvt. Ltd.; Suneeta Carbons; Calgon Carbon Corporation; Karbonous Inc.; Norit; Donau Carbon GmbH





Customization scope



Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.





Pricing and purchase options



Avail customized purchase options to meet your exact research needs. Explore purchase options




 

Global Activated Carbon For Pharma & Healthcare Market Report Segmentation

This report forecasts volume & revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global activated carbon for pharma & healthcare market report based on form, application, and region:

Global Activated Carbon For Pharma & Healthcare Market Report Segmentation


Form Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)



Powdered       



Granular



Other Form





Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)



API Production



Finished Drug Production



Others





Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)



 



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
admin
  • Website

Related Posts

Supplements that are wary of severe drug-induced liver injuries in the United States

May 21, 2025

Why people who eat high protein should eat more fiber

May 21, 2025

Saudi Arabia's Healthcare Information Systems Market Forecast

May 13, 2025
Leave A Reply Cancel Reply

Top Posts

Why people who eat high protein should eat more fiber

May 21, 2025

How To Unlock A Windows PC Without The Password?

January 14, 2021
7.2

Best Chanel Perfume of 2024 – Top Chanel Fragrance Worth Buying

January 15, 2021

Is It Safe to Use an Old or Used Phone? Report Card

January 14, 2021
Don't Miss

Northern Ireland braces for ‘painful’ cuts to fund nurse pay deal

By adminMay 30, 2025

Northern Ireland’s health service is expected to face a £600m budget shortfall, after the health…

New study to investigate domestic abuse of nurses

May 30, 2025

WHO renews global nursing and midwifery strategy until 2030

May 29, 2025

NMC appoints substantive strategy and insight director

May 29, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

About Us
About Us

Welcome to HomeCareNews.us, your trusted source for comprehensive information on home healthcare services. Our mission is to empower individuals and families by providing accurate, up-to-date, and insightful information about essential home care services in USA.

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks

Home care providers use strategies to attract and retain the next generation of workers

May 30, 2025

Alliance appoints new leaders, Harmonycares expands C-Suite

May 30, 2025

Northern Ireland braces for ‘painful’ cuts to fund nurse pay deal

May 30, 2025
Most Popular

Why people who eat high protein should eat more fiber

May 21, 2025

How To Unlock A Windows PC Without The Password?

January 14, 2021
7.2

Best Chanel Perfume of 2024 – Top Chanel Fragrance Worth Buying

January 15, 2021
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
© 2025 HomecareNews.US

Type above and press Enter to search. Press Esc to cancel.